EPAM Systems acquires Odysseus Data Services to bolster health data analytics capabilities

In a significant move within the digital transformation and health analytics sectors, EPAM Systems, Inc. (NYSE: EPAM) has announced its acquisition of Odysseus Data Services, Inc., a leader in health data analytics. This strategic acquisition aims to enhance EPAM’s capabilities in transforming the life sciences value chain through advanced data analytics, data methodologies, and artificial intelligence (AI).

Strategic Implications and Future Potential

EPAM Systems, headquartered in Newton, Pennsylvania, is renowned for its comprehensive services in product engineering and digital transformation. The integration of Odysseus will leverage its existing expertise and expand its reach in the life sciences sector, particularly through the application of Real-World Evidence (RWE) and Real-World Data (RWD). These elements are crucial for connecting multiple segments of the life sciences value chain, offering improved outcomes for EPAM’s diverse clientele.

Greg Killian, Senior Vice President of Life Sciences at EPAM, expressed enthusiasm about the acquisition: “We are pleased to have Odysseus join EPAM. With their strong capabilities in Real-World Evidence and Real-World Data—the ‘glue’ between multiple segments of the life sciences value chain—our natural synergies make this an exciting time to add this to our portfolio to help our clients achieve better outcomes.”

EPAM Systems acquires Odysseus Data Services, Inc to enhance its life sciences data analytics capabilities.

The acquisition is poised to drive the next wave of innovation in the life sciences sector, particularly with the application of standardized data to power AI and Generative AI, enhancing research, clinical studies, and post-market surveillance.

Odysseus’s Role in Health Data Analytics

Based in Cambridge, Massachusetts, Odysseus Data Services, Inc. is at the forefront of generating actionable healthcare data insights. With a robust focus on skilled data science and analytics, software engineering, and data management, Odysseus has cemented its role as a pivotal player in enhancing the effectiveness and efficiency of healthcare interventions.

Gregory Klebanov, CEO of Odysseus, shared his perspective on joining EPAM: “We’re excited to join the EPAM family. With EPAM’s strong foundation in AI, machine learning, data analytics and data management, and cloud infrastructure combined with our healthcare data analytics and Real World Evidence expertise, we can address the whole life sciences value chain more comprehensively.”

This acquisition not only signifies a substantial enhancement of EPAM’s service offerings but also strengthens its position as a leader in digital transformation and health data analytics. By incorporating Odysseus’s expertise, EPAM is well-positioned to lead in the life sciences industry, driving innovation and delivering superior outcomes.